Sign in Create account

Veerhealth Care Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 511523
₹49.58
Sept. 30, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #140 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Sun Pharmaceutical Industries Limited 435,863 146.5 13.7% 11.0% — 72 8 30
Divi's Laboratories Limited 246,660 83.9 15.3% 62.7% 0.32% 70 4 51
Torrent Pharmaceuticals Limited 162,454 78.2 12.2% 34.6% 0.79% 56 0 31
Zydus Lifesciences Limited 115,910 33.3 17.3% 17.2% 0.09% 74 24 84
Cipla Limited 108,736 35.4 11.2% -11.0% 0.97% 73 29 62
Laurus Labs Limited 106,969 122.5 17.1% 127.1% — 78 24 53
Mankind Pharma Limited 103,406 47.4 11.7% 2.6% — 68 12 86
Dr. Reddy's Laboratories Limited 102,916 154.7 10.9% -0.9% — 62 33 71
Veerhealth Care Limited (this stock) 99 65.2 2.4% 151.7% — 51 45 54

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value
₹103 Cr
EV / EBITDA
23.4x
EV / Sales
1.95x
Market cap / Sales
1.87x
Earnings yield
1.53%

Quarterly Financials

Download CSV
Standalone Consolidated
↑ Positive
Quarterly Revenue

Jun 2026 quarterly revenue is Rs 25 Cr, up 388.5% YoY.

↑ Positive
Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 1 Cr, up 409.1% YoY.

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 25 1 1 ₹0.6100
March 31, 2026 17 0 -0 ₹-0.1800
Dec. 31, 2025 7 0 0 ₹0.2000
Sept. 30, 2025 4 0 0 ₹0.1300
June 30, 2025 4 0 0 ₹0.1200
March 31, 2025 6 -0 — ₹-0.0500
Dec. 31, 2024 4 0 0 ₹0.0400
Sept. 30, 2024 5 0 0 ₹0.1500
June 30, 2024 2 0 0 ₹0.0600
March 31, 2024 3 0 -1 ₹-0.2600
Dec. 31, 2023 3 0 0 ₹0.0900
Sept. 30, 2023 4 0 0 ₹0.1900
June 30, 2023 4 0 0 ₹0.3300

Quarterly income statement (standalone, ₹ Cr)

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
Total income (before exceptional items)251774564524344
Operating revenue251774464523344
Other income00-00100000000
Operating expenses231663564523343
Operating profit2111-0-000-00000
Operating profit margin7.7%4.4%17.0%13.3%-0.8%-2.9%4.0%9.4%-0.6%5.2%6.2%5.6%12.1%
Depreciation0000000000000
Interest0000000000000
Exceptional items, gain / (loss)—-0————————-0——
Profit before tax10000-00000000
Tax0100—-0—001000
Net profit1-0000—000-1000
EPS0.61-0.180.200.130.12-0.050.040.150.06-0.260.090.190.33
Net profit (TTM)21————-0000———
EPS (TTM)0.760.270.400.240.260.20-0.010.040.080.351.621.991.99

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 25Mar 24Mar 23Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Total income (before exceptional items) 32.3% 23.1% 33†18†15†14†11†12†12†6†6†2†
Operating revenue 34.8% 25.2% 32†17†14†13†10†11†12†6†5†2†
Other income — — 1†1†1†1†2†1†0†0†1†0†
Operating expenses — — 30†16†13†—10†11†11†6†5†2†
Operating profit — 105.8% 2†0†1†—-1†0†1†0†-0†0†
Operating profit margin — — 7.6%†2.8%†7.3%†—-8.9%†0.6%†6.0%†7.4%†-2.4%†1.5%†
Depreciation — — 1†1†1†1†1†0†0†0†0†0†
Interest — — 0†0†0†—0†0†0†0†0†0†
Exceptional items, gain / (loss) — — -0†0†-0†0†0†0†0†0†0†0†
Profit before tax 3.2% 16.9% 1†1†1†1†0†1†1†0†0†0†
Tax — — ——1†-0†0†0†0†0†——
Net profit — 7.5% 1†—0†—-0†0†0†0†0†0†
EPS -46.7% -13.6% 0.27†0.20†0.35†1.78†-0.14†0.56†0.45†———

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 25Mar 24Mar 23Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Operating margin7.6%†2.8%†7.3%†—-8.9%†0.6%†6.0%†7.4%†-2.4%†1.5%†
EBIT margin5.1%†4.6%†9.2%†—3.0%†7.5%†7.1%†6.9%†6.2%†8.1%†
PBT margin3.9%†3.0%†9.1%†8.6%†2.5%†5.4%†5.5%†6.4%†4.8%†2.8%†
Net margin1.7%†—2.7%†—-1.0%†3.6%†2.7%†2.6%†2.7%†2.3%†
Interest coverage4.13x†2.93x†163.08x†—6.00x†3.64x†4.41x†12.02x†4.53x†1.53x†
Dividend payout——————————
Earnings retention——————————
Current ratio1.37x3.06x————————
Quick ratio1.04x2.37x————————
Debt to equity0.20x0.22x————————
Return on equity2.4%†—————————
Return on assets1.2%†—————————
Return on capital employed5.4%†2.6%†————————
Asset turnover0.74x†0.49x†————————

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 4 -4 -0 5 -1
March 31, 2025 -0 -8 10 9 -9

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 44 23 3 1 4 18 13 0 23 4
March 31, 2025 34 22 2 1 4 11 4 1 20 2

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.